Vasopressors to treat refractory septic shock
Authors:
- 1 June 2020
- journal article
- review article
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 86 (5) , 537-545
Abstract
Article: Vasopressors to treat refractory septic shock - Minerva Anestesiologica 2020 May;86(5):537-45 - Minerva Medica - JournalsKeywords
This publication has 63 references indexed in Scilit:
- The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotensionCritical Care, 2013
- Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shockIndian Journal of Critical Care Medicine, 2010
- Angiotensin II in experimental hyperdynamic sepsisCritical Care, 2009
- Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock modelCritical Care, 2009
- Decreased vasopressin responsiveness in vasodilatory septic shock–like conditions*Critical Care Medicine, 2006
- Refractory septic shock: Efficacy and safety of very high doses of norepinephrineMethods and Findings in Experimental and Clinical Pharmacology, 2006
- TERLIPRESSIN IN CATECHOLAMINE-RESISTANT SEPTIC SHOCK PATIENTSShock, 2004
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*Critical Care Medicine, 2004
- Administration of angiotensin II in refractory septic shockCritical Care Medicine, 1991